|
Pharmaceutical giant Bristol-Myers Squibb (BMS) makes big bucks on matters of the heart. The company's blockbuster cardiovascular line-up includes heart disease drug Plavix, as well as Pravachol (which lowers cholesterol) and Avapro (for hypertension). BMS also makes antipsychotic medication Abilify and drugs in a number of other therapeutic categories, particularly oncology, virology (including HIV), and autoimmune disease. Through its Mead Johnson subsidiary, BMS makes Enfamil infant formula and other nutritional products for children. The company, which has more than 30 manufacturing plants worldwide and 10 R&D centers in five countries, sells its products globally; the US accounts for about half of sales.
|
| | | Contact Information | |
Address: |
345 Park Ave.
New York, NY 10154-0037
| | Phone: | 212-546-4000 | | Fax: | 212-546-4020 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 20597.00 M | | Revenue Growth (1 yr): | 6.50% | | Employees (2008): | 35,000 | | Employee Growth (1 yr): | (-16.70%) |
|
|
Key People
| | • |
Chairman and CEO:
James M. (Jim) Cornelius
| | • |
President, COO, and Director:
Lamberto Andreotti
| | • |
EVP and CFO:
Jean-Marc Huet
|
|
|
